Finding the cause for unexplained acute hepatitis
Part of Digestive system, Infections clinical trials.
This study looks for better ways to find and diagnose hepatitis when the cause is not clear. If you join, doctors will monitor your condition and test samples to try to identify what's causing your liver inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms of acute hepatitis, like yellowing skin or eyes, tiredness, or belly pain.
- Your doctor suspects hepatitis but doesn't know what's causing it, or it's from a virus other than the usual ones.
- You might have a new or rarely seen infection causing your hepatitis.
- You agree to take part and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at people with unexplained high liver enzymes (ALT or AST) that have persisted for at least 6 months. Researchers want to understand what might be causing these elevations and are comparing them to people with normal liver tests.
This study is looking at how the immune system responds in children with acute hepatitis A (a liver infection). Participation may help doctors better understand the body's natural defenses and improve care for other children.
This trial studies what happens to people with hepatitis B who have hepatitis B surface antigen for more than 6 months, are “HBeAg-negative,” and have certain blood and liver-scarring levels despite normal or near-normal liver inflammation. It may help doctors understand the best care for this specific group before clear treatment phases.
This trial is for children and teens (0–17 years) who are in the hospital or emergency department with acute hepatitis (sudden liver inflammation). The study aims to learn more about the condition and how to best treat it.
This study collects information and blood samples from people with autoimmune hepatitis and other liver conditions to better understand these diseases. Taking part may help with research, though it is not a treatment trial.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
Hear when a new Hepatitis of Unknown Aetiology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.